Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old
Publication Date: July 31, 2021
Last Updated: July 24, 2022
Summary of Key Action Statements
Infants 8 to 21 d of age (KASs 1-7): Clinicians…
KAS 1: Should obtain urine specimen by catheterization or suprapubic aspiration (SPA) of bladder for urinalysis and, if urinalysis result is positive, for culture.
(A, Strong)328602
KAS 2: Should obtain a blood culture.
(A, Strong)328602
KAS 3: May assess inflammatory markers (IMs).
(B, Weak)328602
KAS 4: Should obtain CSF for analysis (WBC, protein, glucose, Gram stain) and culture for bacteria. See notes for viral testing.
(A, Strong)328602
KAS 5: Should initiate parenteral antimicrobial therapy.
(A, Strong)328602
KAS 6: Should actively monitor infants while awaiting results of bacterial cultures in a hospital setting with nurses and staff experienced in the care of neonates/young infants.
(B, Moderate)328602
KAS 7a: Should discontinue parenteral antimicrobial agents and discharge hospitalized patients when all of the following criteria are met: (1) culture results are negative for 24–36 h or only positive for contaminants; (2) the infant continues to appear clinically well or is improving (eg, fever, feeding); (3) tare no other reasons for hospitalization.
(B, Strong)328602
KAS 7b: Should treat infants’ positive bacterial pathogens in urine, blood, or CSF with targeted antimicrobial therapy for the duration of time consistent with the nature of the disease, responsible organism, and response of the infant to treatment.
(A, Strong)328602
Title
Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old
Authoring Organization
American Academy of Pediatrics